• NEWS

    NEWS

    THE LATEST NEWS, DEVELOPMENTS AND ANNOUNCEMENTS AS THEY HAPPEN

    more
  • EVENTS

    EVENTS

    CONFERENCES, TRADE SHOWS, LIVE WEBCASTS, NEW LAUNCHES, SEMINARS AND TRAINING EVENTS

    more
  • COMPANIES

    COMPANIES

    PARTNERS, SOLUTIONS & SERVICE PROVIDERS, SUPPLIERS AND INDUSTRY ORGANIZATIONS

    more
  • RESOURCES

    RESOURCES

    WHITEPAPERS, MARKET REPORTS, RESEARCH, ON-DEMAND WEBINARS, VIDEOS AND INFOGRAPHICS

    more

NEWS

   

EVENTS

Conferences

4th International Conference on Food Microbiology and Food Market

4TH INTERNATIONAL CONFERENCE ON FOOD MICROBIOLOGY AND FOOD MARKET

March 20-21, 2019
This is the finest opportunity to interact with participants from the Food Microbiology associations, Food Biotechnology Associations, Food Microbiology Societies, and Food Science Academicians. It mainly concerns on the modern impact and technologies in Food Microbiology and other relevant to Food ...

PITTCON 2019 ANNUAL CONFERENCE & EXPO

PITTCON 2019 ANNUAL CONFERENCE & EXPO

March 17-21, 2019
Pittcon is the world’s leading annual conference and exposition on laboratory science. Pittcon attracts attendees from industry, academia, and government from over 90 countries worldwide. Pittcon is made up of the Spectroscopy Society of Pittsburgh (SSP) and the Society for Analytical Chemists...

2nd International Conference on Cancer Diagnosis & Treatment

2ND INTERNATIONAL CONFERENCE ON CANCER DIAGNOSIS & TREATMENT

March 20-21, 2019
Cancer Diagnosis and Treatment conference 2019 will acts as a forum for Directors, Professors, Researchers, Oncologists, Cancer Specialist, Students, Foundation Leaders, Industrial Professional, Statisticians, Clinicians, Academicians, Medical Oncologists and others from all over the world to share ...

4th International Conference on Cancer Research

4TH INTERNATIONAL CONFERENCE ON CANCER RESEARCH

March 20-21, 2019
The 4th International Conference on Cancer Research is scheduled for March 20-21, 2019 in Amsterdam, Netherlands. This Cancer 2019 conference will be organized around the theme “Scope of Researches in the field of Cancer”. This conference is the best opportunity for those who have center...

15th International Conference and Exhibition on  Nanomedicine and Pharmaceutical Nanotechnology

15TH INTERNATIONAL CONFERENCE AND EXHIBITION ON NANOMEDICINE AND PHARMACEUTICAL NANOTECHNOLOGY

March 18-19, 2019
15th International Conference and Exhibition on Nanomedicine and Pharmaceutical Nanotechnology aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Nanotechnology and Nanomedicine. It also...

SUPERBUGS & SUPERDRUGS 2019

SUPERBUGS & SUPERDRUGS 2019

March 19-19, 2019
Inspiring the global commitment required to tackle multidrug-resistance among bacteria populations, as the global threat of antimicrobial resistance continues to grow. This year’s event will gather leaders from pharmaceutical companies, academia, and the wider scientific community together wit...

Future Healthcare Exhibition & Conference 2019

FUTURE HEALTHCARE EXHIBITION & CONFERENCE 2019

March 18-19, 2019
Showcase your products and services at the UK’s only healthcare event attracting buyers from 65 countries. Organized in association with the UK International Healthcare Management Association, Future Healthcare has emerged as an epicenter for VIP buyers from all over the world. Each year ...

3rd International Conference on Microbial Ecology & Eco Systems

3RD INTERNATIONAL CONFERENCE ON MICROBIAL ECOLOGY & ECO SYSTEMS

March 18-19, 2019
Conference Series LLC LTD takes immense pleasure & feels honored in inviting the contributors across the globe to attend 3rd International Conference on Microbial Ecology & Eco Systems to be held during March 18-19, 2019 at Chicago, USA on the theme "Recent Approaches to Enhance Researc...

 

Webinars

MAR 20, 2019 | 11:00 AM
IMPLEMENTING BYOD ACROSS PHASE II AND III CLINICAL TRIALS
The significant advantages for electronic patient-reported outcomes (ePRO) over paper records include improved compliance, data quality, and patient experiences – these advantages will best be realized only when Bring Your Own Device (BYOD) for the collection of patient-reported outc...
MAR 20, 2019 | 9.00 AM
USING AI MULTIPLEX BIOMARKER ANALYSIS FOR DEEPER INSIGHTS INTO THE TUMOR MICROENVIRONMENT
The interaction of tumor cells and the tumor microenvironment (TME) is a highly complex, heterogeneous system, and individual for each patient. Multiple biomarkers can help improve our understanding, but current standard analysis tests are limited by the insights they can reveal. A tissue-...
MAR 20, 2019 | 8.00 AM
MANIPULATING TRYPSIN DIGESTION CONDITIONS TO ACCELERATE DIGESTION AND IMPROVE SIGNAL INTENSITY FOR BUILDING A PROTEIN-BASED MASS SPECTROMETRIC ASSAY
Multiple aspects need to be considered when building a protein-based mass spectrometric assay such as the selection of signature peptide, calibration matrix and the choice of internal standard (isotopic labeled protein or peptide).  Proteins are reduced to peptides prior to mass spect...
MAR 21, 2019 | 10.00 AM
MAB INDUSTRY IN CHINA : BIOSIMILARS VS INNOVATIVE BIOLOGICS
Following patent cliffs for Erbitux, Rituxan, Sandosta_n and several big blockbusters, Herceptin, Avastin are now among the next biosimilar targets. This is creating huge potential for biosimilars, prompting innovators to shift their focus to target more emerging markets which remain untap...
MAR 21, 2019 | 8.00 AM
BIOLOGY BY DESIGN: APPLYING GIGABASES OF DNA TO BIOENGINEERING
For more than 15 years, the costs of DNA sequencing and synthesis have been improving faster than Moore’s Law. The impacts of the improvements made to DNA sequencing are well known: whereas the original Human Genome Project cost several billion dollars, a human genome can be sequence...
MAR 22, 2019 | 12.00 PM
OVERCOMING DRUG RESISTANCE PATTERNS IN NON-RESPONDERS: PROVEN BEST PRACTICES ON INFORMING YOUR CLINICAL STRATEGY
Many standards of care (SOC) treatments in cancer patients result in a clinical outcome of non-response. Drug development companies are trending toward interrogating resistance mechanisms and using this information in advancing their programs and informing personalized approaches to novel ...

PLANTS WITH SUPERPOWERS (GMO) WEBINAR
Sponsored
We’ve all seen non-GMO labels in the grocery store. What does GMO mean and why should we care? In this webinar, Biology Fortified will show how biotechnology can be used to give plants superpowers. We will discuss plant breeding methods, current and future GMO traits, GMO safety, and...
DNA METHYLATION CHANGES DURING CELL DIFFERENTIATION WEBINAR
Sponsored
Listen in as Dr Ballestar discusses an overall perspective on the connections between DNA methylation and other epigenetic marks, as well as the interplay with transcription factors.
THE POTENTIAL OF ENGINEERED HUMAN LIVER CO-CULTURES IN PHENOTYPIC DRUG DISCOVERY FOR LIVER DISEASES
The diverse functions of the liver (i.e. albumin synthesis, glucose and fatty acid metabolism, drug metabolism) can be severely compromised by several diseases. In particular, drug-induced liver injury is a leading cause of drug attrition; hepatitis B virus chronically infects the livers o...
COMBINING TRANSPORTER DATA WITH QUANTITATIVE SYSTEMS TOXICOLOGY MODELING (DILISYM) TO IMPACT DECISIONS IN DRUG DEVELOPMENT
A quantitative systems toxicology (QST) model of drug-induced liver injury (DILI) has been developed through the DILI-sim Initiative over the past 7 years to assist in the safety characterization of compounds in clinical development.  The emerging platform, DILIsym®, is capable of...
THE UTILITY OF MICROSCALE HUMAN LIVER CO-CULTURES FOR INVESTIGATING DRUG TOXICITY OUTCOMES
Drug-induced liver injury (DILI) remains a leading cause of acute liver failures and the attrition of pharmaceuticals in both preclinical and clinical settings. Due to species-specific differences in drug metabolism pathways, animal models do not always fully predict human DILI. Thus, ther...
ENGINEERING MICROPATTERNED CO-CULTURES FOR DRUG DEVELOPMENT
Due to significant differences across species in liver pathways, models of the human liver are used to screen for potential efficacy and/or toxicity of candidate compounds. Such models serve to complement and reduce the number of animals used in studies required by regulatory agencies. How...

RESOURCES

The pharmaceutical and medical industry suffers huge pain, high cost and poor results from conventional biological indicators. This new science of using Enzyme Indicators for measuring decontamination...

Biological processes arise from nature’s inherent complexity, and they involve many components connected with positive and negative feedback, sometimes with redundant circuitry, sometimes with d...

No other problem in cell culturing is as universal as microbial contamination. In order to avoidit, good sterile techniques and thorough culture handling are essential. Beyond that, the CO2 incubator ...

New medicines and diagnostics on the one hand and rising cost pressure as a result, for example, of the launch of generics and biosimilars on the other mean that new, highly efficient methods are requ...

During the cultivation of animal cells the monitoring of nutrients and metabolites has an important role for the controlling strategy of the cell culture. The measurement of glucose and lactate is one...

Design of experiments (DoE) is one of the most important techniques for systematic planning, execution and statistical evaluation of experiments. Although a DoE investigation is executable in one bior...

The development of biosimilars requires extensive physicochemical characterization of biosimilar candidate molecules which should match the quality profile of the reference molecule (originator). Here...

The presented data demonstrates that chemical denaturation is a feasible approach to predict the colloidal long-term stability of biologicals. Moreover, changes in G in dependence of the protein con...

It is the nirvana that Life Sciences organizations have been chasing for the past 30 years. The time is finally now. A digital transformation is taking place in the life sciences industry, from resear...